Inventor
GUZEL MUSTAFA
US34 patents
⚠️ This page may combine multiple inventors who share the name “GUZEL MUSTAFA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VTV THERAPEUTICS LLC
13 patentsUS10287284B2May 14, 2019
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC14 citations93
US9393245B2Jul 19, 2016
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC7 citations84
US10568888B2Feb 25, 2020
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC2 citations73
US10391097B2Aug 27, 2019
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC2 citations73
US11649230B2May 16, 2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC1 citations72
US11130753B2Sep 28, 2021
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10889580B2Jan 12, 2021
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10570126B2Feb 25, 2020
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10030011B2Jul 24, 2018
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10085990B2Oct 2, 2018
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC1 citations62
US9833457B2Dec 5, 2017
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC1 citations62
US9687489B2Jun 27, 2017
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC1 citations62
US12091407B2Sep 17, 2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC0 citations51
TRANSTECH PHARMA INC
5 patentsUS7459472B2Dec 2, 2008
Aryl and heteroaryl compounds, compositions, and methods of use
TRANSTECH PHARMA INC92 citations97
US7906507B2Mar 15, 2011
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC12 citations92
US7727983B2Jun 1, 2010
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC11 citations92
US7790714B2Sep 7, 2010
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC10 citations83
US8383644B2Feb 26, 2013
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
TRANSTECH PHARMA INC3 citations60
TRANSTECH PHARMA LLC
5 patentsUS8703766B2Apr 22, 2014
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA LLC6 citations83
US9120813B2Sep 1, 2015
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA LLC4 citations82
US8933222B2Jan 13, 2015
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA LLC3 citations62
US9175003B2Nov 3, 2015
Substituted azoanthracene derivatives and intermediates for preparation thereof
TRANSTECH PHARMA LLC2 citations60
US8987295B2Mar 24, 2015
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
TRANSTECH PHARMA LLC3 citations60
NOVO NORDISK AS
4 patentsUS7384967B2Jun 10, 2008
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS166 citations98
USRE45670ESep 15, 2015
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS34 citations97
US7541373B2Jun 2, 2009
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS123 citations97
US7897628B2Mar 1, 2011
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS15 citations91
MJALLI ADNAN M M
4 patentsUS8759535B2Jun 24, 2014
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
MJALLI ADNAN M M15 citations92
US8329715B2Dec 11, 2012
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
MJALLI ADNAN M M10 citations92
US8524708B2Sep 3, 2013
Oxadiazoanthracene compounds for the treatment of diabetes
MJALLI ADNAN M M6 citations83
US8853226B2Oct 7, 2014
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
MJALLI ADNAN M M1 citations62